selective monoamine oxidase type‐B inhibitor that enhances central dopaminergic
transmission. Dopamine is thought to be involved in certain cognitive processes such as
working memory. We assessed the effects of rasagiline on cognitive deficits in cognitively
impaired, nondemented patients with Parkinson's disease. This was a randomized, double‐
blind, placebo‐controlled prospective study. Patients with Parkinson's disease receiving …